| abstract |
The present invention relates to a composition comprising, in a physiologically acceptable medium, from 0.001 to 10% by weight of at least one homopolymer or copolymer of (meth) acrylamide, characterized in that it contains an aqueous suspension of nanocapsules comprising a polymeric envelope and a lipid core containing an oily solvent, said nanocapsules being at least partially coated with lecithin. The nanocapsules coated with lecithin make it possible to improve the cutaneous tolerance of acrylamide polymers. |